265 related articles for article (PubMed ID: 16271898)
21. [Treatment of osteoporosis with parathyroid hormone].
Syversen U; Halse JI
Tidsskr Nor Laegeforen; 2008 Jan; 128(1):39-41. PubMed ID: 18183056
[TBL] [Abstract][Full Text] [Related]
22. [Treating with what? Therapy for how long?].
MMW Fortschr Med; 2005 Dec; 147(51-52):62-3. PubMed ID: 16402713
[No Abstract] [Full Text] [Related]
23. [New medication combines osteo-anabolic and anti-resorptive effects. Double strategy against osteoporosis].
MMW Fortschr Med; 2004 Apr; 146(14):47. PubMed ID: 15344760
[No Abstract] [Full Text] [Related]
24. Osteodensitometry in healthy postmenopausal women.
Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
[TBL] [Abstract][Full Text] [Related]
25. Relationship between bone mass, invasive breast cancer incidence and raloxifene therapy in postmenopausal women with low bone mass or osteoporosis.
Burshell AL; Song J; Dowsett SA; Mershon JL; Delmas PD; Secrest RJ; Cauley JA
Curr Med Res Opin; 2008 Mar; 24(3):807-13. PubMed ID: 18254988
[TBL] [Abstract][Full Text] [Related]
26. Hip and non-spine fracture risk reductions differ among antiresorptive agents: Evidence from randomised controlled trials.
Liberman UA; Hochberg MC; Geusens P; Shah A; Lin J; Chattopadhyay A; Ross PD
Int J Clin Pract; 2006 Nov; 60(11):1394-400. PubMed ID: 17026515
[TBL] [Abstract][Full Text] [Related]
27. [Drug selection guide for osteoporosis determined by the clinical staging, pathophysiology and age].
Tanaka I; Oshima H
Nihon Rinsho; 2009 May; 67(5):915-20. PubMed ID: 19432109
[TBL] [Abstract][Full Text] [Related]
28. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture.
Seeman E; Eisman JA
Med J Aust; 2004 Mar; 180(6):298-303. PubMed ID: 15012571
[TBL] [Abstract][Full Text] [Related]
29. Real-world challenges of treating osteoporosis.
Owens G
Am J Manag Care; 2011 May; 17 Suppl 6():S177-84. PubMed ID: 21882487
[TBL] [Abstract][Full Text] [Related]
30. [New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?].
Yamaguchi T; Sugimoto T
Clin Calcium; 2009 Jan; 19(1):38-43. PubMed ID: 19122263
[TBL] [Abstract][Full Text] [Related]
31. Recognition of women at risk for fracture and intervention with fast-acting therapies.
Derman R
Int J Fertil Womens Med; 2006; 51(4):183-90. PubMed ID: 17184104
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study.
Palomba S; Manguso F; Orio F; Russo T; Oppedisano R; Sacchinelli A; Falbo A; Tolino A; Zullo F; Mastrantonio P
Menopause; 2008; 15(4 Pt 1):730-6. PubMed ID: 18698280
[TBL] [Abstract][Full Text] [Related]
33. [Long term effects of raloxifen on the bones].
Eiken PA
Ugeskr Laeger; 2008 Jan; 170(4):224-6. PubMed ID: 18282451
[TBL] [Abstract][Full Text] [Related]
34. Cost effectiveness and cost utility of risedronate for osteoporosis treatment and fracture prevention in women: a Swiss perspective.
Wasserfallen JB; Krieg MA; Greiner RA; Lamy O
J Med Econ; 2008; 11(3):499-523. PubMed ID: 19450101
[TBL] [Abstract][Full Text] [Related]
35. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
Epstein S
Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639
[TBL] [Abstract][Full Text] [Related]
36. Osteoporosis in postmenopausal women. Therapy options across a wide range of risk for fracture.
Miller RG
Geriatrics; 2006 Jan; 61(1):24-30. PubMed ID: 16405361
[TBL] [Abstract][Full Text] [Related]
37. [Compression vertebral fracture in osteoporosis--prevention and treatment].
Vlak T
Reumatizam; 2004; 51(2):50-3. PubMed ID: 15554379
[TBL] [Abstract][Full Text] [Related]
38. Osteoporosis: evaluation and treatment.
Bajaj S; Saag KG
Curr Womens Health Rep; 2003 Oct; 3(5):418-24. PubMed ID: 12959702
[TBL] [Abstract][Full Text] [Related]
39. Osteoporosis: latest innovation in therapy.
Taechakraichana N; Witoonpanich P
J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S126-31. PubMed ID: 21213509
[TBL] [Abstract][Full Text] [Related]
40. [Risk of osteoporosis in postmenopausal women. When is bone density measurement indicated?].
MMW Fortschr Med; 2004 May; 146(21):63. PubMed ID: 15373093
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
